Coronary heart disease (CHD) has become the leading cause of death among women beyond age 60. Knowledge about lipid- lowering or other interventions that may be useful in preventing progression or causing regression of coronary artery atherosclerosis among postmenopausal women is essentially nonexistent. Randomized trails of the effect of plasma cholesterol lowering on CHD have not included women. Observational epidemiologic studies examining the association between estrogen use and CHD in postmenopausal women have reported contradictory results. The significance of this proposed study is that it will provide a foundation for trials in women and may provide a basis for the rational management of hyperlipoproteinemic postmenopausal women. The results of this study will have significance in several areas: a) the study will determine whether and to what extent estrogen replacement decreases coronary artery atherosclerosis among estrogen-deficient postmenopausal monkeys on a cholesterol lowering diet; b) the results will allow us to determine whether and to what extent the addition of a progestin (Provera) to the estrogen replacement therapy will diminish any beneficial effect of estrogen replacement therapy; in subgroup analyses based on the prerandomization data, two additional questions will be answered: c) What is the effect of hormonal therapy on the HDL subclasses and the LDL molecular weight, all known to be associated with atherosclerotic lesions? and finally, d) What is the relationship between the plasma levels of sex hormone binding globulin and the degree of coronary atherosclerosis? The study represents the first effort that we are aware of to utilize the methodology of a randomized trial in a nonhuman primate population to evaluate a coronary atherosclerosis intervention. Moreover, it is a complement to the NIH-sponsored PEPI (Postmenopausal Estrogen/Progestin Interventions) study which is designed to determine the effect of different estrogen/progestin preparations on CHD and osteoporosis risk factors and other factors, as well as their safety.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038964-03
Application #
3355471
Study Section
Special Emphasis Panel (SSS (F))
Project Start
1988-04-01
Project End
1993-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Lacza, Zsombor; Horn, Thomas F W; Snipes, James A et al. (2004) Lack of mitochondrial nitric oxide production in the mouse brain. J Neurochem 90:942-51
Register, T C; Carlson, C S; Adams, M R (2001) Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates. Clin Chem 47:2159-61
Jayo, M J; Register, T C; Carlson, C S (1998) Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys. Bone 23:361-6
Register, T C; Adams, M R; Golden, D L et al. (1998) Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys. Arterioscler Thromb Vasc Biol 18:1164-71
Brosnihan, K B; Weddle, D; Anthony, M S et al. (1997) Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 15:719-26
Cline, J M; Soderqvist, G; von Schoultz, B et al. (1997) Regional distribution of proliferating cells and hormone receptors in the mammary gland of surgically postmenopausal macaques. Gynecol Obstet Invest 44:41-6
Wagner, J D; Martino, M A; Jayo, M J et al. (1996) The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism 45:1254-62
Cline, J M; Soderqvist, G; von Schoultz, E et al. (1996) Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 174:93-100
Kaplan, J R; Adams, M R; Clarkson, T B et al. (1996) Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med 58:598-611
Williams, J K; Anthony, M S; Honore, E K et al. (1995) Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol 15:827-36

Showing the most recent 10 out of 15 publications